CN105561215A - Poria cocos-lucid ganoderma-rhizoma curcumae longae compound preparation - Google Patents
Poria cocos-lucid ganoderma-rhizoma curcumae longae compound preparation Download PDFInfo
- Publication number
- CN105561215A CN105561215A CN201610120066.3A CN201610120066A CN105561215A CN 105561215 A CN105561215 A CN 105561215A CN 201610120066 A CN201610120066 A CN 201610120066A CN 105561215 A CN105561215 A CN 105561215A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- rhizoma curcumae
- curcumae longae
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a poria cocos-lucid ganoderma-rhizoma curcumae longae compound preparation, which is prepared from the following raw materials in parts by weight: 40 to 45 parts of poria cocos extract, 40 to 45 parts of lucid ganoderma extract and 10 to 20 parts of rhizoma curcumae longae extract. According to the preparation which is provided by the invention, three medicines of poria cocos, lucid ganoderma and rhizoma curcumae longae, which are prepared into one preparation, are adopted as the raw materials; the three Chinese herbal medicines all have antitumor effects; the preparation is suitable for middle-aged and elderly people to take; the preparation not only has the effect of treating tumor, but also has the effect of preventing the tumors; the morbidity of tumor diseases to the middle-aged and elderly people is greatly decreased; the physical health of the middle-aged and elderly people is ensured.
Description
Technical field
The present invention relates to health product technology field, be specially a kind of Poria rock and be good for compound preparation.
Background technology
Along with human habitat, living standard and the change of life style and the progress of medical science, disease
Spectrum there occurs significant change, and general infectious disease is controlled gradually, and malignant tumor then becomes day by day normal
See and one of principal disease of serious threat human life and quality of life.According to World Health Organization (WHO) (WHO)
Report, tumor has become the important public hygiene problem of 21 century facing mankind].At present, malignant tumor has become one of most serious disease threatening human health.World Health Organization (WHO) estimates according to regions of the world cancer morbidity, mortality rate and world population data, and malignant tumor person is died from the whole world every year is in recent years 6,900,000 people, and new cases are 8,700,000, and existing ill example is 37,100,000.Malignant tumor causes the loss of a large amount of power, a large amount of consumption of social resources.Malignant tumor returns patient and family brings immeasurable emotional distress.Therefore, malignant tumor has become the significant problem that the whole mankind is concerned about jointly.
Poria is the sclerotium of pore fungi plant Poriacocos (Schw.) Wolf, belongs to medicinal and edible Chinese medicine, has effect of eliminating dampness by diuresis diuresis, stomach function regulating spleen invigorating, mind tranquilizing and the heart calming; Clinically be used for the treatment of edema oliguria, the disease such as have loose bowels in phlegm retention vertigo and palpitation, insufficiency of the spleen lack of appetite, loose stool, irritability, palpitation with fear insomnia, Be very effective; Modern pharmacology research shows, Poria has the biological activity of the aspects such as antitumor, immunity moderation function, antiinflammatory, antiallergic.Su-fuling (Poriatin, triterpenes mixture) the external DNA to mouse leukemia L1210 cell extracted in Poria has obvious irreversible inhibitory action, and inhibitory action strengthens along with the increase of dosage; There is significant inhibitory action to ehrlich carcinoma, sarcoma s180, also have certain inhibitory action to the transfer of Mice Bearing Lewis Lung Cancer.Pachyman also has obvious antitumor action.
Ganoderma is the dry sporophore of On Polyporaceae Ganoderma lucidum (Leyss. Ex Fr.) Karst. Ganodermalucidum (Leyss.exFr.) Karst. or Ganoderma anodermasinenseZhao, XuetZhang.Function invigorating QI and tranquilization, relieving cough and asthma.Clinical in adjuvant chemotherapy and/or radiotherapy in the treatment tumor, chronic bronchitis and asthma, neurasthenia has a sleepless night, and hyperlipidemia, hypertension, diabetes, hepatitis, leukopenia, poisonous mushroom is poisoning, also can be used for the health care of person in middle and old age and sub-health population.Pharmacological research shows there is the caused damage of immunomodulating, antiallergic, antitumor, antagonism radiotherapy and chemotherapy, improve Learning and Memory obstacle, the reparation of promotion maincenter and peripheral nerve injury, reduce blood pressure, adjusting blood lipid, the effects such as blood sugar lowering and suppression diabetic complications (kidney, injury of testis).Triterpenoid compound in Ganoderma has the effect directly suppressing kinds of tumors, and polysaccharide is by regulating the immunologic function of human body, indirect Tumor suppression.
Rhizoma Curcumae Longae is the dry rhizome of zingiberaceous plant Rhizoma Curcumae Longae CurcumalongaL..The circulation of qi promoting of function removing blood stasis, inducing menstruation to relieve menalgia.Principle active component is curcumin, has antitumor, mutation, antimutagenic, resisting HIV, antioxidation, blood fat reducing and antiatherogenic effect.
Summary of the invention
A kind of Poria rock is the object of the present invention is to provide to be good for compound preparation, to solve the problem proposed in above-mentioned background technology.
For achieving the above object, the invention provides following technical scheme: a kind of Poria rock is good for compound preparation, its material composition weight ratio is Poria extract 40-45 part, Ganoderma extract 40-45 part and Rhizoma Curcumae Longae extract 10-20 part.
Preferably, its material composition weight ratio described is Poria extract 43 parts, Ganoderma extract 43 parts and Rhizoma Curcumae Longae extract 14 parts.
Preferably, its material composition weight ratio described is Poria extract 40 parts, Ganoderma extract 43 parts and Rhizoma Curcumae Longae extract 17 parts.
Preferably, its material composition weight ratio described is Poria extract 42 parts, Ganoderma extract 42 parts and Rhizoma Curcumae Longae extract 16 parts.
Compared with prior art, the invention has the beneficial effects as follows: the preparation that raw material of the present invention adopts Poria, Ganoderma and Rhizoma Curcumae Longae three medicine to unify, three kinds of Chinese herbal medicine all have antineoplastic action, be applicable to middle-aged and elderly people practical, not only there is the effect for the treatment of tumor, and there is the effect of prophylaxis of tumours, greatly reduce the sickness rate of middle-aged and elderly people oncosis, ensure the healthy of middle-aged and elderly people.
Detailed description of the invention
Be clearly and completely described the technical scheme in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment one
A kind of Poria rock is good for compound preparation, and its material composition weight ratio described is Poria extract 43 parts, Ganoderma extract 43 parts and Rhizoma Curcumae Longae extract 14 parts.
Embodiment two
A kind of Poria rock is good for compound preparation, and its material composition weight ratio described is Poria extract 40 parts, Ganoderma extract 43 parts and Rhizoma Curcumae Longae extract 17 parts.
Embodiment three
A kind of Poria rock is good for compound preparation, and its material composition weight ratio described is Poria extract 42 parts, Ganoderma extract 42 parts and Rhizoma Curcumae Longae extract 16 parts.
The formula material weight ratio of constituents that the preferred Poria rock of the present invention is good for is Poria extract 43 parts, Ganoderma extract 43 parts and Rhizoma Curcumae Longae extract 14 parts.
Although illustrate and describe embodiments of the invention, for the ordinary skill in the art, be appreciated that and can carry out multiple change, amendment, replacement and modification to these embodiments without departing from the principles and spirit of the present invention, scope of the present invention is by claims and equivalents thereof.
Claims (4)
1. Poria rock is good for a compound preparation, it is characterized in that: its material composition weight ratio is Poria extract 40-45 part, Ganoderma extract 40-45 part and Rhizoma Curcumae Longae extract 10-20 part.
2. a kind of Poria rock according to claim 1 is good for compound preparation, it is characterized in that: its material composition weight ratio described is Poria extract 43 parts, Ganoderma extract 43 parts and Rhizoma Curcumae Longae extract 14 parts.
3. a kind of Poria rock according to claim 1 is good for compound preparation, it is characterized in that: its material composition weight ratio described is Poria extract 40 parts, Ganoderma extract 43 parts and Rhizoma Curcumae Longae extract 17 parts.
4. a kind of Poria rock according to claim 1 is good for compound preparation, it is characterized in that: its material composition weight ratio described is Poria extract 42 parts, Ganoderma extract 42 parts and Rhizoma Curcumae Longae extract 16 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610120066.3A CN105561215A (en) | 2016-03-03 | 2016-03-03 | Poria cocos-lucid ganoderma-rhizoma curcumae longae compound preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610120066.3A CN105561215A (en) | 2016-03-03 | 2016-03-03 | Poria cocos-lucid ganoderma-rhizoma curcumae longae compound preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105561215A true CN105561215A (en) | 2016-05-11 |
Family
ID=55872220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610120066.3A Pending CN105561215A (en) | 2016-03-03 | 2016-03-03 | Poria cocos-lucid ganoderma-rhizoma curcumae longae compound preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105561215A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109349640A (en) * | 2018-12-10 | 2019-02-19 | 金木集团有限公司 | A kind of health-caring capsule improving chemical damage |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007026A (en) * | 2006-01-24 | 2007-08-01 | 黄振华 | An anticancer medicinal composition, preparing method and use thereof |
| CN103110889A (en) * | 2013-02-01 | 2013-05-22 | 北京东方红航天生物技术股份有限公司 | Traditional Chinese medicine for increasing immunity and preparation method thereof |
-
2016
- 2016-03-03 CN CN201610120066.3A patent/CN105561215A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007026A (en) * | 2006-01-24 | 2007-08-01 | 黄振华 | An anticancer medicinal composition, preparing method and use thereof |
| CN103110889A (en) * | 2013-02-01 | 2013-05-22 | 北京东方红航天生物技术股份有限公司 | Traditional Chinese medicine for increasing immunity and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 彭成等: "《中药药理学》", 31 December 2014, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109349640A (en) * | 2018-12-10 | 2019-02-19 | 金木集团有限公司 | A kind of health-caring capsule improving chemical damage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101664428B (en) | Broccoli polyphenol capsules | |
| CN102697035A (en) | Cordyceps anti-aging pellet | |
| CN104887617B (en) | A kind of composition for eye-care and preparation method thereof | |
| CN108853366A (en) | A kind of drug that can promote and improve sleep quality and its production method | |
| CN103479963A (en) | Traditional Chinese medicine capsules for treating rheumatoid arthritis and preparation method thereof | |
| CN105294811A (en) | Method for preparing ganoderma lucidum karst triterpenic acid and ganoderma lucidum karst polysaccharide with Nyingchi ganoderma lucidum karst as material | |
| CN102357208B (en) | Traditional Chinese medicine composition for treating diabetes, hyperglycemia, hypertension, and hyperlipidemia | |
| CN107468999A (en) | A kind of fermentation composition with beauty treatment and eliminating spot function and preparation method thereof | |
| CN104206575A (en) | Health-caring tea capable of reducing blood pressure, blood fat and blood glucose and preventing hypertension, hyperlipoidemia and hyperglycemia and preparation method thereof | |
| CN105561215A (en) | Poria cocos-lucid ganoderma-rhizoma curcumae longae compound preparation | |
| CN104887971A (en) | Traditional Chinese medicine for treating cancers | |
| JP2011184349A (en) | Frequent urination-ameliorating composition, healthy food and blood flow-ameliorating composition | |
| CN104257883A (en) | Traditional Chinese medicine composition for treating leucopenia after chemotherapy | |
| CN103202886B (en) | Traditional chinese medicine composition and preparation method thereof | |
| CN109731016A (en) | A kind of Chinese medicine composition for treating breast cancer and preparation method thereof and drug | |
| CN105454821A (en) | Chinese wolfberry fruit and cordyceps sinensis liver preparation method | |
| CN103381232B (en) | Anticancer traditional Chinese medicine and its preparation method | |
| CN103230418A (en) | Mycelium extract for helicobacter pylori-resistant biological medicine and preparation technology thereof | |
| CN103768454A (en) | Composition for preventing and treating HIV/AIDS (Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome) and preparation method thereof | |
| CN107174603A (en) | A kind of Chinese medicine of anti-aging | |
| CN102000244B (en) | Traditional Chinese medicine preparation for treating diabetes mellitus | |
| CN1853711A (en) | Xinmaikangzhong Chinese medicinal composition and preparation thereof | |
| CN104719898A (en) | Health food for treating acquired immune deficiency syndrome and preparation method thereof | |
| CN1927237A (en) | Use of Chinese sealavender for preparing antineoplastic drug | |
| CN103393766A (en) | Natural pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160511 |